The Pharmacogenetics of Asthma
Progress toward Personalized Medicine

Kelan Tantisira, M.D., M.P.H.
Assistant Professor, Harvard Medical School
Associate Physician, Brigham and Women’s Hospital

The inaugural lecture in the annual Joseph V. Scaletti Memorial Catalyst Lecture series was presented by Kelan Tantisira, MD MPH.  Dr. Tantisira’s research centers on the pharmacogenetics of asthma. Pharmacogenetics promises to revolutionize the treatment of disease by tailoring the treatment to each individual, based upon that individual’s genetic makeup.  Pharmacogenetics is already improving drug safety, increasing the effectiveness of existing drug treatments, and aiding in the discovery of new drugs by taking the uniqueness of each individual patient’s potential response to the drug into account.